rabeprazole has been researched along with Mucositis, Oral in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The subjects were 88 patients with gastroesophageal reflux disease (GERD), who had changes in the oral cavity typical of this disease." | 1.33 | [Oral cavity manifestations of gastroesophageal reflux disease]. ( Barer, GM; Burkov, SG; Busarova, GA; Gurenev, GL; Maev, IV; Polikanova, EN; Pustovoĭt, EV, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maev, IV | 1 |
| Barer, GM | 1 |
| Busarova, GA | 1 |
| Pustovoĭt, EV | 1 |
| Polikanova, EN | 1 |
| Burkov, SG | 1 |
| Gurenev, GL | 1 |
1 other study available for rabeprazole and Mucositis, Oral
| Article | Year |
|---|---|
[Oral cavity manifestations of gastroesophageal reflux disease].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esophagus; Female; Follo | 2005 |